The U.S. Food and Drug Administration (FDA) has seized all supplies from Michigan-based generic drug maker Caraco, a move that affects 33 medications and could lead to a shortage of one painkiller. The FDA made this move after Caraco failed to meet its current Good Manufacturing Practice requirements, which assure the quality of manufactured drugs. Caraco makes generic versions of cardiac, psychiatric, and pain medications, including the painkiller choline magnesium trisalicylate, which could...
Read moreWe have know for years that many people with diabetes have too little magnesium in their bodies. So why don’t all of us take supplements... Read more »
Reader's Question: I have been told that Fosamax is coming out in generic form. I have been taking a brand name osteoporosis drug (in the... Read more »
I've been taking Wellbutrin (generic name Bupropion) for about seven years, minus the time I was pregnant with my son. I would say that... Read more »
It's finally here! Merck's patent on the popular osteoporosis drug Fosamax has run out, and now other companies are offering generic... Read more »
It's been seven weeks since I had my baby. The time is really flying by and soon my maternity leave will be over. I've been slowly... Read more »
Drugmaker Ethex Corporation is recalling dozens of drugs, including generic formulas of OxyContin, Toprol XL, and Norvasc, because of potential... Read more »
The Indian drug company Dr Reddy's Laboratories Ltd says that the U.S. Food and Drug Administration has approved a generic, over-the-counter version... Read more »
Officials at the Federal Trade Commission (FTC) say the 12- to 14-year patent-protection period given to biologic medications is too long to "promote... Read more »
Are you willing to change pharmacies to save money on prescription drugs? With Wal-Mart stores in 49 states now offering $4 generic prescription... Read more »
As pressure from insurers increases for people to switch to cheaper generic drugs, some question whether these generic substitutes are as effective... Read more »